ATE292970T1 - Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden - Google Patents

Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden

Info

Publication number
ATE292970T1
ATE292970T1 AT02779378T AT02779378T ATE292970T1 AT E292970 T1 ATE292970 T1 AT E292970T1 AT 02779378 T AT02779378 T AT 02779378T AT 02779378 T AT02779378 T AT 02779378T AT E292970 T1 ATE292970 T1 AT E292970T1
Authority
AT
Austria
Prior art keywords
brucin
composition containing
topical composition
skin damage
treating skin
Prior art date
Application number
AT02779378T
Other languages
English (en)
Inventor
Anthony Vila
Original Assignee
Boyle Frank
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boyle Frank filed Critical Boyle Frank
Application granted granted Critical
Publication of ATE292970T1 publication Critical patent/ATE292970T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02779378T 2001-09-20 2002-09-18 Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden ATE292970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20010841 2001-09-20
PCT/EP2002/010522 WO2003024454A2 (en) 2001-09-20 2002-09-18 Topical composition containing brucine and the use for the treatment of damaged mammalian skin

Publications (1)

Publication Number Publication Date
ATE292970T1 true ATE292970T1 (de) 2005-04-15

Family

ID=11042839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02779378T ATE292970T1 (de) 2001-09-20 2002-09-18 Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden

Country Status (9)

Country Link
US (1) US20040248930A1 (de)
EP (1) EP1434582B1 (de)
CN (1) CN1304004C (de)
AT (1) ATE292970T1 (de)
AU (1) AU2002342718B2 (de)
DE (1) DE60203726T2 (de)
ES (1) ES2242075T3 (de)
NZ (1) NZ532332A (de)
WO (1) WO2003024454A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100594027C (zh) * 2001-12-05 2010-03-17 张喜田 番木鳖碱、马钱子碱和一叶秋碱及其盐的透皮剂
CN101972259B (zh) * 2010-06-08 2012-04-25 北京大学 马钱子碱及其衍生物在制备治疗酒精滥用和依赖药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531570A (en) * 1967-04-03 1970-09-29 American Home Prod Method of tranquilizing or anti-depressant treatment with alkaloid derivatives
US5378461A (en) * 1991-07-12 1995-01-03 Neigut; Stanley J. Composition for the topical treatment of skin damage
JP3623548B2 (ja) * 1995-06-01 2005-02-23 協和醗酵工業株式会社 化粧料
MY124445A (en) * 1995-10-12 2006-06-30 Ono Foods Ind Co Ltd Method of drying foods by using far infrared rays at reduced pressure and temperature
US5747021A (en) * 1997-01-10 1998-05-05 Mckenzie; Therman After shave treatment composition
CN100594027C (zh) * 2001-12-05 2010-03-17 张喜田 番木鳖碱、马钱子碱和一叶秋碱及其盐的透皮剂

Also Published As

Publication number Publication date
US20040248930A1 (en) 2004-12-09
DE60203726D1 (de) 2005-05-19
CN1304004C (zh) 2007-03-14
DE60203726T2 (de) 2006-02-09
AU2002342718B2 (en) 2007-10-18
CN1556704A (zh) 2004-12-22
WO2003024454A2 (en) 2003-03-27
ES2242075T3 (es) 2005-11-01
WO2003024454A3 (en) 2003-08-28
EP1434582B1 (de) 2005-04-13
NZ532332A (en) 2006-11-30
EP1434582A2 (de) 2004-07-07

Similar Documents

Publication Publication Date Title
TR200200068T2 (tr) Nematisital triflüorobütenler
ATE353880T1 (de) Neue verwendung von pyrimidin- oder triazin-2- carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2- carbonsäurenitrilderivate
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
DE602004017736D1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
DE60143061D1 (de) Verwendung von Botulinum Toxin zur Behandlung von Gelenkschmerzen
ATE438630T1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
DE60036169D1 (de) Methoden zur Behandlung der Hautpigmentierung
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
ATE494884T1 (de) Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
NO991974L (no) 5-HT1F agonister
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
ATE384699T1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE148109T1 (de) Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69827387D1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
ATE292970T1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden
ATE455579T1 (de) Sojaprodukte enthaltende zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties